HSBC Holdings’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SFM
BH
AC
VCM
RA
WCM
BAM
HSBC Holdings's ANGO Position: Q1 2026 in Review
HSBC Holdings increased its AngioDynamics (ANGO) stake by 9.4% in Q1 2026, buying an estimated $63.8K and bringing the position to 68,255 shares worth $773K. The position accounts for ﹤0.01% of the portfolio, ranked #1997.
HSBC Holdings first reported a position in ANGO in Q3 2013 and has held it in 20 quarters since. The position peaked at $801K in Q4 2025. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.
- HSBC Holdings held 68,255 shares of AngioDynamics worth $773K as of Q1 2026.
- HSBC Holdings bought 5,888 AngioDynamics shares in Q1 2026, an estimated $63.8K.
- AngioDynamics made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #1997 holding.
- HSBC Holdings first reported a position in AngioDynamics in Q3 2013 and has held it in 20 quarters since.
- HSBC Holdings's AngioDynamics position peaked at $801K in Q4 2025.
- 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.